Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 4/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | XIAP | P98170 | 12/20 | 0.50 |
| ▸ | NPY1R | P25929 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9405558 | 0.87 | XIAP (0.58) | GHSRAGTR1XIAP | |
| SCHEMBL9025303 | 0.87 | XIAP (0.58) | GHSRAGTR1XIAP | |
| SCHEMBL9405632 | 0.86 | XIAP (0.71) | XIAP | |
| SCHEMBL9562958 | 0.86 | XIAP (0.57) | GHSRAGTR1XIAP | |
| SCHEMBL9024436 | 0.85 | GHSR (0.65) | GHSRAGTR1XIAPNPY1R | |
| SCHEMBL9023962 | 0.85 | GHSR (0.65) | GHSRAGTR1XIAPNPY1R | |
| SCHEMBL9025262 | 0.84 | GHSR (0.61) | GHSRAGTR1XIAPNPY1R | |
| SCHEMBL9405556 | 0.84 | GHSR (0.56) | GHSRAGTR1XIAP | |
| SCHEMBL9023896 | 0.84 | GHSR (0.48) | GHSRAGTR1XIAP | |
| SCHEMBL9025272 | 0.84 | GHSR (0.48) | GHSRAGTR1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | ELIXIR PHARMACEUTICALS, INC. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | GLS2, STS, ABAT | GHSR 3083/4885AGTR1 4158/4885XIAP 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.